Orthofix Medical Inc. announced that Catherine Burzik, Chair of the Orthofix Board, has been appointed Interim Chief Executive Officer. The appointment is effective immediately and follow the unanimous decision by the Board's independent directors to terminate for cause Keith Valentine from the respective role. Catherine Burzik, age 72, was re-appointed Chair of the Orthofix Board in June 2023.

She previously served as the Company's Chair of the Board from 2021 to 2022 before assuming the position of Lead Independent Director of the new combined board that was formed from the merger of SeaSpine and Orthofix. She was President and Chief Executive Officer of Kinetic Concepts Inc. from 2006 until the Company's sale in 2011. Prior to that, Ms. Burzik served as President of Applied Biosystems Group and held senior executive positions at Eastman Kodak and Johnson Johnson, including Chief Executive Officer and President of Kodak Health Imaging Systems and President of Ortho-Clinical Diagnostics Inc. Currently Ms. Burzik is a member of the Board of Directors of Becton, Dickinson and Company, where she Chairs the Quality and Regulatory Compliance Committee and serves on the Corporate Governance and Nominating Committee.

Additionally, she serves as Chairman Emeritus of StemBioSys Inc. and Chairman Emeritus of the American College of Wound Healing and Tissue Repair. Ms. Burzik previously served on the Board of Directors for the San Antonio Branch of the Dallas Federal Reserve Board, Allscripts Inc., Bausch Lomb, Cordis Corporation, Haemonetics Corporation and AdvaMed. In 2019, Ms. Burzik received the AdvaMed Lifetime Achievement Award that honors accomplishments of pioneers in the medical technology industry whose contributions have had a significant impact on patients' lives and the industry as an essential part of America's economy.

She holds a Bachelor of Arts in Mathematics from Canisius University and a Master of Arts Degree in Mathematics from the University of Buffalo.